Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
98052232 | 9805223 | 2 | F | 20131202 | 20160912 | 20140109 | 20160924 | EXP | BR-AMGEN-BRASP2014000901 | AMGEN | 51.00 | YR | A | F | Y | 60.00000 | KG | 20160924 | CN | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
98052232 | 9805223 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, ONCE WEEKLY | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||||
98052232 | 9805223 | 2 | SS | CHLOROQUINE. | CHLOROQUINE | 1 | Unknown | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
98052232 | 9805223 | 1 | Rheumatoid arthritis |
98052232 | 9805223 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
98052232 | 9805223 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
98052232 | 9805223 | Blindness | |
98052232 | 9805223 | Drug ineffective | |
98052232 | 9805223 | Emotional disorder | |
98052232 | 9805223 | Injection site erythema | |
98052232 | 9805223 | Pain | |
98052232 | 9805223 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
98052232 | 9805223 | 1 | 20131202 | 0 |